Promising results were obtained, because, by blocking IL-7 production, a reduction in SG inflammation was observed, along with an improvement in functionality [63]; using an experimental mouse model of SS, an IL-7 block led to restored levels of AQP5, improving the manifestations of SS [63]. This evidence concerns the gene AQP5 and synovial sarcoma.